drugset / Trial / NCT03342001

Hypothyroidism Treated With Calcitonin

NCT03342001

Phase 4 Completed 11 enrolled University of Maryland, Baltimore
NaSingle-groupOpen-labelTreatment

Summary

Some people with hypothyroidism have persistent symptoms despite adequate treatment with thyroid hormones. We are testing whether giving calcitonin to such people will improve their quality of life.

Timeline

Start
2018-06-18
Primary completion
2019-06-30
Completion
2019-08-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitonin Protein / enzyme biologic 200 ug Intranasal

Indications